7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.6% per year over the past 5 years.
Operating margin has contracted, at -11541.5% in the latest year.
Financial health
Total debt ($18M) exceeds cash ($5M); net debt is $13M.
Operating income covered interest expense -8.6× in the latest year.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$200000
-$26M
78.5%
-11541.5%
-$19M
$18M
$5M
2024
$342000
-$39M
79.5%
-9676.3%
-$21M
—
$12M
2023
$654000
-$50M
81.5%
-6198.8%
-$31M
—
$29M
2022
$473000
-$30M
94.5%
-10234.5%
-$44M
—
$18M
2021
$723000
-$10M
60.0%
-6912.6%
-$36M
—
$50M
2020
$206000
-$19M
0.0%
-9812.6%
-$19M
—
$59M
2019
—
-$16M
—
—
-$13M
—
$9M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$15000
-$8M
100.0%
-13740.0%
—
$18M
$6M
Dec '25
$77000
-$9M
70.1%
-9733.8%
-$5M
$18M
$5M
Sep '25
$15000
-$9M
100.0%
-37653.3%
-$4M
$18M
$8M
Jun '25
$27000
-$7M
100.0%
-21718.5%
-$5M
$16M
$7M
Mar '25
$81000
-$751000
75.3%
-5032.1%
-$5M
$17M
$10M
Dec '24
$91000
-$14M
80.2%
-9511.0%
-$5M
—
$12M
Sep '24
$87000
-$8M
79.3%
-8982.8%
-$3M
—
$15M
Jun '24
$91000
-$7M
80.2%
-8122.0%
-$6M
—
$22M
Mar '24
$73000
-$11M
78.1%
-12646.6%
-$7M
—
$22M
Dec '23
$170000
-$10M
77.6%
-5841.2%
-$7M
—
$29M
Sep '23
$108000
-$2M
88.9%
-8835.2%
-$7M
—
$42M
Jun '23
$269000
-$25M
75.5%
-3842.4%
-$7M
—
$49M
Mar '23
$107000
-$12M
95.3%
-10029.9%
-$9M
—
$18M
Dec '22
$234000
-$1M
97.0%
-4988.5%
-$9M
—
$18M
Sep '22
$174000
-$11M
89.1%
-5635.1%
-$10M
—
$7M
Jun '22
$35000
-$5M
100.0%
-38842.9%
-$11M
—
$7M
Mar '22
$30000
-$13M
100.0%
-44453.3%
-$14M
—
$13M
Dec '21
$199000
$4M
0.0%
-7064.3%
-$10M
—
$50M
Sep '21
$110000
$29M
0.0%
-9500.0%
-$8M
—
$61M
Jun '21
$201000
-$3M
0.0%
-6853.2%
-$9M
$13M
$63M
Valuation over time
How the market has priced CLNN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 30.4× (Mar '23) to 368.7× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CLNN growing its revenue and profit?
Over the past 5 years, Clene Inc.'s revenue has declined 0.6% per year. These are computed facts, not advice.
How much debt does CLNN have?
As of FY2025, Clene Inc. reported $18M of total debt against $5M of cash; operating income covered interest expense -8.6×.
What is CLNN's profit margin?
In FY2025, gross margin was 78.5%, operating margin -11541.5%, and net margin -13086.5%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.